Marijuana Stock Report for Friday, September 21, 2018
Marijuana stocks have remained on a high during the month of September and pre market trading has a number of these cannabis stocks heading higher. Traders have flocked to medical-marijuana producers like Tilray (TLRY), for instance, after the company won approval from the Drug Enforcement Administration to import a cannabis product drug into the U.S. for a clinical trial.
However, since Tilray soared to its $300 highs, the stock has pulled back and left the door open for other pot stocks to take the spotlight. With this being the case, there are multiple cannabis companies to look at as the October date in Canada comes closer.